Italian hospitals surveyed on gene test that could spare cancer patients unneeded treatment
NCT ID NCT07555665
First seen May 06, 2026 · Last updated May 06, 2026
Summary
This study surveys about 264 Italian hospitals that treat endometrial cancer to find out how often they use a test called POLE testing. POLE testing helps doctors know which patients have a very low risk of cancer coming back, so they can safely skip extra treatments like radiation or chemotherapy. The goal is to understand current practices and identify gaps to improve care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione Policlinico Universitario Agostino Gemelli, IRCCS
RECRUITINGRoma, Roma, 00186, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.